sertindole
Sign in to saveAlso known as sertindol, 1-(2-{4-[5-chloro-1-(4-fluorophenyl)-indol-3-yl]-1-piperidyl}ethyl)imidazolidin-2-one
Sertindole, sold under the brand name Serdolect among others, is an antipsychotic medication. Sertindole was developed by the Danish pharmaceutical company Lundbeck and marketed under license by Abbott Labs. Like other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia.
Key facts
- Drug.ChemSpiderID
- 54229
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 464389408
- Drug.image
- Sertindole.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 225px
- Drug.image2
- Sertindole ball-and-stick model.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 250px
- Drug.tradename
- Serdolect, others
- Drug.pregnancy_AU
- C
- Drug.routes_of_administration
- Oral
- Drug.class
- Atypical antipsychotic
- Drug.ATC_prefix
- N05
- Drug.ATC_suffix
- AE03
- Drug.legal_AU
- S4
- Drug.legal_status
- Rx-only
- Drug.bioavailability
- 75%
via Wikipedia infobox
Research
517 papers- Sertindole for schizophrenia.The Cochrane database of systematic reviews · 2005
- Sertindole for the treatment of schizophrenia.Expert opinion on pharmacotherapy · 2010
- Sertindole for schizophrenia.The Cochrane database of systematic reviews · 2000
- Sertindole in schizophrenia: efficacy and safety issues.Expert opinion on pharmacotherapy · 2014
- Sertindole: efficacy and safety in schizophrenia.Expert opinion on pharmacotherapy · 2006
via PubMed
Wikidata facts
- Mass
- 440.177917
Show 5 more facts
- defined daily dose
- 16
- chemical formula
- C₂₄H₂₆ClFN₄O
- canonical SMILES
- C1CN(CCC1C2=CN(C3=C2C=C(C=C3)Cl)C4=CC=C(C=C4)F)CCN5CCNC5=O
- World Health Organisation international non-proprietary name
- sertindole
- Commons category
- Sertindole
via Wikidata · CC0
~6 min read
Article
9 sectionsContents
- Medical uses
- Adverse effects
- Pharmacology
- Chemistry
- Safety and status
- United States
- European Union
- See also
- References
Sertindole, sold under the brand name Serdolect among others, is an antipsychotic medication. Sertindole was developed by the Danish pharmaceutical company Lundbeck and marketed under license by Abbott Labs. Like other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia.
Sertindole is not approved for use in the United States and was discontinued in Australia in January 2014.